MTOR and isolated focal cortical dysplasia type II: Recent studies have shown that phosphorylated RPS6 (p-RPS6), initially believed to be a hallmark of mTOR hyperactivity in FCD type II and TSC pathologies, is actually a marker of dysmorphic and immature neurons in a wide range of pathologies associated with DREs30–32.